It was found that SLC1A4 overexpression is a powerful prognostic biomarker and is accompanied by cancer cell cycle progression, metabolism, oncogenic pathways, proliferation, and migration, while it mediates apoptosis suppression. Here, SLC1A4 is linked to cancer.